SRRM4 and neoplasm: Surprisingly, we find that not only are SRRM4 and its microexon program globally down-regulated in cancer despite having low basal inclusion in normal nonneural tissues, but also in fact SRRM4 is the most consistently down-regulated across tumor types out of all SFs analyzed.